Guilherme Baldo - Concepedia

Author

Guilherme Baldo

Universidade Federal do Rio Grande do Sul ORCID

Also Known As

Baldo, Guilherme, Filippo Vairo, G Baldo, G. Baldo, Guilherme Baldo, Guilherme Valdir Baldo, Roberto Giugliani

224

Publications

1.8K

Citations

H-Index

133

Concepts

All Affiliations

Universidade Federal do Rio Grande do Sul Hospital de Clínicas de Porto Alegre Washington University in St. Louis National Institute on Population Medical Genetics

About

Guilherme Baldo is an author at Universidade Federal do Rio Grande do Sul specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	37	941
2	Engineering	6	6	191
3	Health Sciences	4	4	73
4	Public Health	2	2	85
5	Social Sciences	1	1	13

Guilherme Baldo

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system Roselena Silvestri Schuh, Édina Poletto, Gabriela Pasqualim, Journal of Controlled Release Knockout MouseOff-target EffectEngineeringGenome SurgeryIn Vivo Gene Therapy	2018	68
Enzyme replacement therapy started at birth improves outcome in difficult-to-treat organs in mucopolysaccharidosis I mice Guilherme Baldo, Fabiana Quoos Mayer, Barbara Martinelli, Molecular Genetics and Metabolism Translational MedicineEnzyme Replacement TherapyPathologyDifficult-to-treat OrgansMedicine	2013	58
Lysosomal diseases: Overview on current diagnosis and treatment Fabiano de Oliveira Poswar, Filippo Pinto e Vairo, Maira Graeff Burin, Genetics and Molecular Biology Protein DeficienciesEnzyme Replacement TherapyGeneticsGenetic EpidemiologyPathology	2019	55
Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation Guilherme Baldo, Susan Wu, Ruth A. Howe, Molecular Genetics and Metabolism InflammationComplement SystemAutoimmune DiseaseDisease PathophysiologyGranulocyte	2011	48
Bone marrow derived cells decrease inflammation but not oxidative stress in an experimental model of acute myocardial infarction Ângela Maria Vicente Tavares, Alex Sander da Rosa Araújo, Guilherme Baldo, Life Sciences	2010	45
The progression of pulmonary arterial hypertension induced by monocrotaline is characterized by lung nitrosative and oxidative stress, and impaired pulmonary artery reactivity Alexsandra Zimmer, Rayane Brinck Teixeira, Rosalia Lempk Constantin, European Journal of Pharmacology HypertensionPulmonary Arterial HypertensionPulmonary CirculationCardiovascular DiseaseMedicine	2020	45
Gene editing of MPS I human fibroblasts by co-delivery of a CRISPR/Cas9 plasmid and a donor oligonucleotide using nanoemulsions as nonviral carriers Roselena Silvestri Schuh, Talita Giacomet de Carvalho, Roberto Giugliani, European Journal of Pharmaceutics and Biopharmaceutics Gene TherapiesCrispr/cas9 PlasmidEngineeringGenetic EngineeringDonor Oligonucleotide	2017	43
Role of inflammation, oxidative stress, and autonomic nervous system activation during the development of right and left cardiac remodeling in experimental pulmonary arterial hypertension Alexsandra Zimmer, Rayane Brinck Teixeira, Jéssica Hellen Poletto Bonetto, Molecular and Cellular Biochemistry HypertensionHeart FailurePulmonary Arterial HypertensionPulmonary CirculationCardiovascular Disease	2019	40
Neonatal nonviral gene editing with the CRISPR/Cas9 system improves some cardiovascular, respiratory, and bone disease features of the mucopolysaccharidosis I phenotype in mice Roselena Silvestri Schuh, Esteban Alberto Gonzalez, Ângela Maria Vicente Tavares, Gene Therapy Knockout MouseGene TherapiesBone Disease FeaturesPathogenesisImmunology	2019	34
Evidence of a progressive motor dysfunction in Mucopolysaccharidosis type I mice Guilherme Baldo, Fabiana Quoos Mayer, Barbara Martinelli, Behavioural Brain Research Mucopolysaccharidosis TypeNeurological DisorderMotor ControlProgressive Motor DysfunctionNeuroscience	2012	31

Page 1